Effect of food on the bioavailability and tolerability of the JAK2-selective inhibitor fedratinib (SAR302503): Results from two phase I studies in healthy volunteers

2014 ◽  
Vol 4 (4) ◽  
pp. 315-321 ◽  
Author(s):  
Meng Zhang ◽  
Christine Xu ◽  
Lei Ma ◽  
Elias Shamiyeh ◽  
Jianyun Yin ◽  
...  
Keyword(s):  
Phase I ◽  
Healthy Volunteers ◽  
Selective Inhibitor ◽  
Two Phase ◽  
Phase I Studies ◽  
Effect Of Food

scholarly journals Romidepsin and lenalidomide based regimens have efficacy in relapsed/refractory lymphoma: combined analysis of two phase I studies with expansion cohorts

2021 ◽  
Author(s):  
Neha Mehta‐Shah ◽  
Matthew A. Lunning ◽  
Alison J. Moskowitz ◽  
Adam M. Boruchov ◽  
Jia Ruan ◽  
...  
Keyword(s):  
Phase I ◽  
Two Phase ◽  
Phase I Studies ◽  
Combined Analysis ◽  
Refractory Lymphoma

scholarly journals Relative Bioavailability of Orally Dispersible Tablet Formulations of Levo‐ and Racemic Praziquantel: Two Phase I Studies

2018 ◽  
Vol 12 (1) ◽  
pp. 66-76 ◽  
Author(s):  
Wilhelmina Maria Bagchus ◽  
Deon Bezuidenhout ◽  
Eleanor Harrison‐Moench ◽  
Elly Kourany‐Lefoll ◽  
Peter Wolna ◽  
...  
Keyword(s):  
Phase I ◽  
Relative Bioavailability ◽  
Two Phase ◽  
Phase I Studies ◽  
Dispersible Tablet ◽  
Tablet Formulations

scholarly journals Brentuximab Vedotin in Transplant‐Naïve Patients with Relapsed or Refractory Hodgkin Lymphoma: Analysis of Two Phase I Studies

2012 ◽  
Vol 17 (8) ◽  
pp. 1073-1080 ◽  
Author(s):  
Andres Forero‐Torres ◽  
Michelle Fanale ◽  
Ranjana Advani ◽  
Nancy L. Bartlett ◽  
Joseph D. Rosenblatt ◽  
...  
Keyword(s):  
Phase I ◽  
Hodgkin Lymphoma ◽  
Brentuximab Vedotin ◽  
Two Phase ◽  
Phase I Studies ◽  
Refractory Hodgkin Lymphoma
Sign in / Sign up

Export Citation Format

Share Document